GMED - Globus Medical, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$102.17
DETAILS
HIGH:
$115.00
LOW:
$64.00
MEDIAN:
$111.00
CONSENSUS:
$102.17
UPSIDE:
11.15%
Market Cap:
12.30B
Volume:
2,018,292
Avg Volume:
1,421,455
52 Week Range:
51.79-101.4
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.06
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
5,300
IPO Date:
2012-08-03
EPS (TTM):
0.76
P/E Ratio:
21.95
Revenue (TTM):
2.52B
Total Assets:
5.25B
Total Debt:
537.19M
Cash & Equiv:
784.44M
Rev Growth (5Y):
26.2%
EPS Growth (5Y):
-13.5%
FCF Growth (5Y):
32.0%
ROCE:
5.0%
Debt/Equity:
0.13
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $1.18 | $0.78 | +51.1% | $769.0M | $734.7M | +4.7% |
| 2025-08-07 | $0.86 | $0.76 | +13.2% | $745.3M | $742.7M | +0.4% |
| 2025-05-08 | $0.68 | $0.74 | -8.6% | $598.1M | $625.9M | -4.4% |
| 2025-02-20 | $0.84 | $0.74 | +13.5% | $657.3M | $645.7M | +1.8% |
| 2024-11-05 | $0.83 | $0.65 | +28.3% | $625.7M | $604.7M | +3.5% |
| 2024-08-06 | $0.75 | $0.68 | +10.3% | $629.7M | $615.3M | +2.3% |
| 2024-05-07 | $0.72 | $0.57 | +27.0% | $606.7M | $586.8M | +3.4% |
| 2024-02-20 | $0.60 | $0.59 | +1.7% | $616.5M | $607.1M | +1.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.52B | 1.57B | 1.02B | 958.10M | 789.04M | 785.37M | 712.97M | 635.98M | 563.99M | 544.75M | 474.37M | 434.46M |
| Net Income | 102.98M | 122.87M | 190.17M | 149.19M | 102.28M | 155.21M | 156.47M | 107.35M | 104.34M | 112.78M | 92.48M | 68.61M |
| EPS | 0.76 | 1.09 | 1.89 | 1.48 | 1.04 | 1.57 | 1.60 | 1.12 | 1.09 | 1.19 | 0.98 | 0.74 |
| Total Assets | 5.25B | 5.09B | 2.08B | 1.96B | 1.68B | 1.53B | 1.30B | 1.08B | 927.64M | 834.10M | 703.55M | 566.30M |
| Total Debt | 537.19M | 520.40M | 6.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 784.44M | 467.29M | 150.47M | 193.07M | 239.40M | 195.72M | 139.75M | 118.82M | 66.95M | 60.15M | 82.27M | 89.96M |
| Operating Cash Flow | 520.64M | 243.50M | 178.47M | 276.27M | 198.79M | 171.97M | 181.64M | 159.53M | 171.89M | 121.96M | 79.17M | 93.47M |
| Free Cash Flow | 405.21M | 165.22M | 104.42M | 219.38M | 135.13M | 101.22M | 121.95M | 108.23M | 130.98M | 71.20M | 54.42M | 69.79M |
| FCF per Share | 2.99 | 1.46 | 1.04 | 2.18 | 1.37 | 1.02 | 1.25 | 1.12 | 1.37 | 0.75 | 0.58 | 0.75 |
| Book Value | 4.18B | 4.00B | 1.85B | 1.74B | 1.51B | 1.40B | 1.19B | 967.78M | 832.08M | 715.32M | 585.45M | 472.36M |
| Cash & ST Investments | 890.06M | 517.79M | 446.06M | 443.45M | 426.74M | 311.49M | 339.68M | 373.71M | 290.31M | 281.03M | 228.70M | 238.92M |
| ROC Equity | 0.02 | 0.03 | 0.10 | 0.09 | 0.07 | 0.11 | 0.13 | 0.11 | 0.13 | 0.16 | 0.16 | 0.15 |